Target intelligence / Profile preview

Trypanosoma DNA

Molecular classification
Other, Mitochondrial DNA (kDNA), Nuclear DNA
01

Overview

Trypanosomal DNA consists of both nuclear and mitochondrial DNA, with the latter forming a complex catenated structure known as the kinetoplast. Kinetoplast DNA (kDNA) is essential for parasite survival, cell cycle progression, and infection. Replication and repair of this DNA require specialized enzymes, including unique DNA polymerases (such as POLIB, POLIC, and POLID in *T. brucei*)—each with specialized functions for mitochondrial DNA maintenance and repair. The nuclear DNA encodes the parasite’s major genes, while the mitochondrial kDNA supports essential oxidative phosphorylation processes. Trypanosomal DNA is targeted by drugs that induce DNA damage, inhibit replication, or disrupt essential repair processes, making it central to therapeutic intervention and diagnosis in trypanosomiasis. Overall, the term "Trypanosomal DNA" is broad and does not refer to a unique molecular target (receptor, enzyme, etc.), but it is often used as an umbrella descriptor for genetic or drug studies; greater specificity is typically necessary for scientific and therapeutic utility.

Other names
Trypanosomal kDNAKinetoplast DNATrypanosoma brucei DNATrypanosoma cruzi DNA
02

Mechanism of action

DNA damage induction (e.g., nitrofuran drugs produce reactive species that damage kDNA and nuclear DNA); Inhibition of DNA replication (targeting DNA polymerases or replication factors); Binding to the DNA minor groove or other DNA structures to interfere with function; Inhibition of repair enzymes (e.g., PARP inhibitors that affect DNA repair).

03

Biological functions

Genetic information storageReplicationTranscriptionDNA repairAntigenic variation regulation (e.g., transcriptional control of VSG genes)
04

Disease associations

Infection (protozoan parasitic diseases: African sleeping sickness, Chagas disease)Other (target for diagnostic assays, species identification, and study of drug resistance)
05

Safety considerations

Host cell DNA toxicity (off-target effects of DNA-damaging drugs)Resistance via mutations in DNA repair and replication machinerySelectivity (some drugs that target trypanosomal enzymes may also affect host enzymes)
06

Interacting drugs

Nifurtimox

4 more in the full profile.

07

Biomarkers

Species-specific kinetoplast DNA sequences (used for diagnostic PCR-based detection)Variant surface glycoprotein (VSG) gene expression patterns

Beyond the preview

Go deeper on Trypanosoma DNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trypanosoma DNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call